What is Bio-Path Holdings' latest development in treating obesity in Type 2 diabetes patients? [Yahoo! Finance]
FOXO Technologies Inc. (FOXO)
Company Research
Source: Yahoo! Finance
The preclinical studies showed that BP1001-A reduced Grb2 protein expression in myoblast cells and increased the levels of phosphorylated AKT and phosphorylated FOXO-1 in myoblast and hepatoma cells in the presence of insulin. Was this helpful? Yes No What is Bio-Path Holdings' latest development in treating obesity in Type 2 diabetes patients? Bio-Path Holdings has announced preclinical testing of BP1001-A, which has shown to enhance insulin sensitivity in Type 2 diabetes patients by downregulating growth factor receptor-bound protein 2 (Grb2) expression. Was this helpful? Yes No How does BP1001-A work to treat obesity in Type 2 diabetes patients? BP1001-A works by downregulating Grb2 expression, which increases insulin sensitivity and helps lower blood glucose levels in Type 2 diabetes patients by affecting insulin signaling and the insulin/phosphoinositol-3 kinase (PI3K)/AKT pathway. Was this helpful? Yes No What are the next steps for BP1001-A in its d
Show less
Read more
Impact Snapshot
Event Time:
FOXO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FOXO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FOXO alerts
High impacting FOXO Technologies Inc. news events
Weekly update
A roundup of the hottest topics
FOXO
News
- FOXO TECHNOLOGIES INC. ANNOUNCES THAT STOCKHOLDERS EQUITY IS GREATER THAN $4M, WHICH IS REQUIRED TO MEET THE CONTINUED LISTING REQUIREMENTS OF THE NYSE AMERICAN EXCHANGEGlobeNewswire
- FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER [Yahoo! Finance]Yahoo! Finance
- FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICERGlobeNewswire
- FOXO TECHNOLOGIES INC. ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERS [Yahoo! Finance]Yahoo! Finance
- FOXO TECHNOLOGIES INC. ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERSGlobeNewswire
FOXO
Sec Filings
- 12/17/24 - Form 8-K
- 12/16/24 - Form 8-K
- 12/13/24 - Form PRER14A
- FOXO's page on the SEC website